Ever since I started my investment journey, dividend stocks have remained a favorite, and for good reason. I enjoy the steady ...

The best way to navigate the current market uncertainty is to invest in stocks that have seen the ups and downs and thrived ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple ...

Johnson & Johnson (JNJ) closed at $154.42 in the latest trading session, marking a -0.63% move from the prior day.

Johnson & Johnson (JNJ) posts Phase 3 trial win for Akkega plus prednisone in metastatic castration-sensitive prostate cancer ...

Johnson & Johnson shows strong profitability and solid value, but faces growth uncertainty, legal risks, and pricing ...

J&J’s JNJ stock has declined 6.4% in the past three months. J&J faces several challenges, including slowing sales in the ...

Shares of Kenvue (NYSE:KVUE) are under pressure Tuesday and experiencing their worst day since splitting from Johnson & ...

Johnson & Johnson MedTech has launched its Kincise 2 surgical automated power tool system for knee and hip procedures, and ...

Larry Jones, the former CIO of Johnson & Johnson MedTech, has joined Microsoft as its global Healthcare & Life Sciences (HLS) ...